论文信息 - Crystallography and the development of therapeutic medicines - 字舞流文

Crystallography and the development of therapeutic medicines

Advances in crystallography and cryo-EM promise to further enhance the proud role crystallography has played in the development of new medicines.

Edward N. Baker | E. Baker

[1] D. Julius,et al. TRPV1 structures in nanodiscs reveal mechanisms of ligand and lipid action , 2016, Nature.

[2] C. Fishwick,et al. The potential use of single-particle electron microscopy as a tool for structure-based inhibitor design , 2017, Acta crystallographica. Section D, Structural biology.

[3] Shaun Rawson,et al. X-ray and cryo-EM structures of inhibitor-bound cytochrome bc 1 complexes for structure-based drug discovery , 2018, IUCrJ.

[4] H. Chapman,et al. Mix-and-diffuse serial synchrotron crystallography , 2017, IUCrJ.

[5] Dimitri Argyriou. Does crystallography need a new name? , 2017, IUCrJ.

[6] W. Kühlbrandt. The Resolution Revolution , 2014, Science.

[7] T. Blundell. Protein crystallography and drug discovery: recollections of knowledge exchange between academia and industry , 2017, IUCrJ.

[8] A. Bartesaghi,et al. 2.3 Å resolution cryo-EM structure of human p97 and mechanism of allosteric inhibition , 2016, Science.

[9] E. Carpenter,et al. Overcoming the challenges of membrane protein crystallography , 2008, Current opinion in structural biology.

[10] Richard Henderson,et al. CryoEM at IUCrJ: a new era , 2016, IUCrJ.

[11] Harren Jhoti,et al. Twenty years on: the impact of fragments on drug discovery , 2016, Nature Reviews Drug Discovery.

[12] E. Baker,et al. Using X-Ray Crystallography to Simplify and Accelerate Biologics Drug Development. , 2017, Journal of pharmaceutical sciences.